Helicobacter pylori is a gram-negative bacterium which causes chronic
gastritis and plays important roles in peptic ulcer disease, gastric c
arcinoma, and gastric lymphoma. H. pylori has been found in the stomac
hs of humans in all parts of the world. In developing countries, 70 to
90% of the population carries H. pylori. In developed countries, the
prevalence of infection is lower. There appears to be no substantial r
eservoir of H. pylori aside from the human stomach. Transmission can o
ccur by iatrogenic, fecal-oral, and oral-oral routes. H. pylori is abl
e to colonize and persist in a unique biological niche within the gast
ric lumen. All fresh isolates of H. pylori express significant urease
activity, which appears essential to the survival and pathogenesis of
the bacterium. A variety of tests to diagnose H. pylori infection are
now available. Histological examination of gastric tissue, culture, ra
pid urease testing, DNA probes, and PCR analysis, when used to test ga
stric tissue, all require endoscopy. In contrast, breath tests, serolo
gy, gastric juice PCR, and urinary excretion of [N-15]ammonia are noni
nvasive tests that do not require endoscopy. In this review, we highli
ght advances in the detection of the presence of the organism and meth
ods of differentiating among types of H. pylori, and we provide a back
ground for appropriate chemotherapy of the infection.